Medizinische Universit├Ąt Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Buchacher, L; Richtig, G; Dernoscheg, M; Richtig, E; Koch, L.
Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.
J Eur Acad Dermatol Venereol. 2023; Doi: 10.1111/jdv.18871
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Koch Lukas
Co-authors Med Uni Graz
Dernoscheg Marie-Therese
Richtig Erika
Richtig Georg
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):


© Med Uni GrazImprint